Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats

Hypertension

Volumn 52, Issue 2, 2008, Pages 322-329

  Demel, Stacie L ^a,b   Galligan, James J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ATP; Excitatory junction potential; P2X receptors; Sympathetic nervous system; Vascular neuroeffector junction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DEOXYCORTICOSTERONE ACETATE; NORADRENALIN; OMEGA CONOTOXIN GVIA; DEOXYCORTICOSTERONE; PURINERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; EXCITATORY JUNCTION POTENTIAL; HYPERTENSION; IN VITRO STUDY; MALE; MESENTERIC ARTERY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; INNERVATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUE;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; ENDOTHELIAL CELLS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; PROBABILITY; RANDOM ALLOCATION; RATS; RECEPTORS, PURINERGIC; SENSITIVITY AND SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES;

EID: 49849099181     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.110353     Document Type: Article

References (41)

1. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension. 2007;50:547-556.
2. Donoso MV, Steiner M, Huidobro-Toro JP. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5′-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed. J Pharmacol Exp Ther. 1997;282:691-698.
3. Burnstock G, Holman ME. The transmission of excitation from autonomic nerve to smooth muscle. J Physiol. 1961;155:115-133.
4. Bao JX, Gonon F, Stjarne L. Kinetics of ATP- and noradrenaline-mediated sympathetic neuromuscular transmission in rat tail artery. Acta Physiol Scand. 1993;149:503-519.
5. Damase-Michel C, Tavernier G, Llau ME, Chollet F, Senard JM, Bagheri H, Tran MA, Houin G, Guiraud-Chaumeil B, Montastruc JL. Is there any desensitization of presynaptic alpha 2-adrenergic receptors in hypertension? Experimental and clinical studies [in French]. Arch Mal Coeur Vaiss. 1992;85:1149-1151.
6. Damase-Michel C, Tran MA, Llau ME, Chollet F, Senard JM, Guiraud-Chaumeil B, Montastruc JL, Montastruc P. The effect of yohimbine on sympathetic responsiveness in essential hypertension. Eur J Clin Pharmacol. 1993;44:199-201.
7. Masuyama Y, Tsuda K, Kuchii M, Nishio I. Peripheral neural mechanism of hypertension in rat models-peripheral sympathetic neurotransmission in hypertension. J Hypertens Suppl. 1986;4:S189-S192.
8. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, Kelly M, Esler MD. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 1993;11:1217-1227.
9. Bouvier M, de Champlain J. Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats. Clin Exp Hypertens A. 1985;7:1629-1645.
10. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1-S7.
11. Park J, Quaiserova-Mocko V, Patel BA, Novotny M, Liu A, Bian X, Galligan JJ, Swain GM. Diamond microelectrodes for in vitro electroanalytical measurements: current status and remaining challenges. Analyst. 2008;133:17-24.
12. Luo M, Hess MC, Fink GD, Olson LK, Rogers J, Kreulen DL, Dai X, Galligan JJ. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosci. 2003;104:47-57.
13. Luo M, Fink GD, Lookingland KJ, Morris JA, Galligan JJ. Impaired function of alpha2-adrenergic autoreceptors on sympathetic nerves associated with mesenteric arteries and veins in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol. 2004;286:H1558-H1564.
14. Moreau P, Drolet G, Yamaguchi N, de Champlain J. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. Am J Hypertens. 1995;8:287-293.
15. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res. 1975;36:300-309.
16. Galligan JJ, Miller SB, Katki K, Supowit S, DiPette D, Fink GD. Increased substance P content in nerve fibers associated with mesenteric veins from deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Regul Pept. 2006;133:97-104.
17. Waterman SA. Voltage-gated calcium channels in autonomic neuroeffector transmission. Prog Neurobiol. 2000;60:181-210.
18. Lin YQ, Graham K, Bennett MR. Depression of transmitter release at synapses in the rat superior cervical ganglion: the role of transmitter depletion. Auton Neurosci. 2001;88:16-24.
19. Sneddon P, Westfall DP. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol. 1984;347:561-580.
20. Sneddon P, Burnstock G. ATP as a co-transmitter in rat tail artery. Eur J Pharmacol. 1984;106:149-152.
21. Tsuda K, Tsuda S, Nishio I, Masuyama Y. Inhibition of norepinephrine release by presynaptic alpha 2-adrenoceptors in mesenteric vasculature preparations from chronic DOCA-salt hypertensive rats. Jpn Heart J. 1989;30:231-239.
22. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43:169-175.
23. Brock JA, Van Helden DF. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch. 1995;430:901-908.
24. Guitart M, Jimenez M, Giraldo J, Gonalons E, Badia A. Changes in electrophysiological properties in the prostatic portion of vas deferens from spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:425-430.
25. Ziogas J, Vessey K. Angiotensin-induced enhancement of excitatory junction potentials evoked by periarteriolar nerve stimulation and vasoconstriction in rat mesenteric arteries are both mediated by the angiotensin AT1 receptor. Pharmacology. 2001;63:103-111.
26. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:340-350.
27. Todorov LD, Mihaylova-Todorova ST, Bjur RA, Westfall DP. Differential cotransmission in sympathetic nerves: role of frequency of stimulation and prejunctional autoreceptors. J Pharmacol Exp Ther. 1999;290:241-246.
28. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA, Westfall DP. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature. 1997;387:76-79.
29. Ekas RD Jr, Steenberg ML, Lokhandwala MF. Increased norepinephrine release during sympathetic nerve stimulation and its inhibition by adenosine in the isolated perfused kidney of spontaneously hypertensive rats. Clin Exp Hypertens A. 1983:5:41-48.
30. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96-106.
31. Zugck C, Lossnitzer D, Backs J, Kristen A, Kinscherf R, Haass M. Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors. J Hypertens. 2003;21:1363-1369.
32. Dunn WR, Brock JA, Hardy TA. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br J Pharmacol. 1999;128:174-180.
33. Tanaka Y, Mochizuki Y, Tanaka H, Shigenobu K. Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric artery. Br J Pharmacol. 1999;128:1602-1608.
34. Pruneau D, Angus JA. Omega-conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br J Pharmacol. 1990;100:180-184.
35. Whorlow SL, Angus JA, Wright CE. Selectivity of omega-conotoxin GVIA for n-type calcium channels in rat isolated small mesenteric arteries. Clin Exp Pharmacol Physiol. 1996;23:16-21.
36. Szeto HH. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. Aaps J. 2006;8:E521-E531.
37. Gunes A, Ceylan A, Sarioglu Y, Stefek M, Bauer V, Karasu C. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundam Clin Pharmacol. 2005;19:73-79.
38. Iriuchijima J, Mizogami S, Sokabe H. Sympathetic nervous activity in renal and DOC hypertensive rats. Jpn Heart J. 1975;16:36-43.
39. Mutafova-Yambolieva VN, Keef KD. Frequency dependent alpha(2)- adrenoceptor mediated modulation of excitatory junction potentials in guinea-pig mesenteric artery. Eur J Pharmacol. 2001;411:123-127.
40. Morikawa T, Tanaka N, Kubota Y, Mizuno H, Nakamura K, Kunitomo M, Shinozuka K. ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate. Clin Exp Pharmacol Physiol. 2007;34:601-605.
41. Marshall I, Burt RP, Chapple CR. Signal transduction pathways associated with alpha1-adrenoceptor subtypes in cells and tissues including human prostate. Eur Urol. 1999;36S:42-47.